Biogen Inc (BIIB)

286.72
3.57 1.26
NASDAQ : Health Care
Prev Close 283.15
Open 284.13
Day Low/High 283.11 / 288.15
52 Wk Low/High 223.02 / 338.51
Volume 916.80K
Avg Volume 1.44M
Exchange NASDAQ
Shares Outstanding 211.43M
Market Cap 59.58B
EPS 17.00
P/E Ratio 18.49
Div & Yield N.A. (N.A)

Latest News

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire

All eyes are on Pfizer in the months ahead.

Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products

Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products

Pfizer post earnings beat.

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences

Biogen (NASDAQ:BIIB) today announced the appointment of Anabella Villalobos, Ph.

Abarca Health Announces Innovative Value-Based Contract With Biogen For Multiple Sclerosis Therapies

Abarca Health Announces Innovative Value-Based Contract With Biogen For Multiple Sclerosis Therapies

The agreement is the first to apply value-based contracts to cover Medicaid patients in the United States.

Abarca Health And Biogen Announces Innovative Value-Based Contract For Multiple Sclerosis Therapies

Abarca Health And Biogen Announces Innovative Value-Based Contract For Multiple Sclerosis Therapies

The agreement is the first to apply value-based contracts to cover patients in Puerto Rico.

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

United Therapeutics, DOJ in Possible Settlement Over Drug Contributions

The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.

Alphabet Did Nothing to Push S&P 500 and Nasdaq to Fresh Records

Alphabet Did Nothing to Push S&P 500 and Nasdaq to Fresh Records

Wall Street at records.

Closing Bell: S&P 500 at Record; Senate Passes Motion to Proceed on Healthcare

Closing Bell: S&P 500 at Record; Senate Passes Motion to Proceed on Healthcare

The S&P 500 and Nasdaq end at records.

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

Novavax, Medicines Co. and Biogen were among the biotech stock movers in premarket trading on July 25.

S&P 500 Hits All-Time High, Alphabet's Fall Pressures Nasdaq

S&P 500 Hits All-Time High, Alphabet's Fall Pressures Nasdaq

Stocks are mixed.

4 Stocks Warren Buffett Would Love

4 Stocks Warren Buffett Would Love

These disparate names seem to fit quite well with the investment approach of the Oracle of Omaha.

Stock Futures Solidly Higher but Alphabet's Earnings Cause Concern

Stock Futures Solidly Higher but Alphabet's Earnings Cause Concern

Stock futures are higher.

The Dow Binges on Earnings

The Dow Binges on Earnings

Get ready for another heavy earnings slate

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens

U.S. stock futures turn higher on Tuesday following earnings from Alphabet.

Biogen Reports Record Quarterly Revenues Of $3.1 Billion, Raises Full Year Revenue Guidance

Biogen Reports Record Quarterly Revenues Of $3.1 Billion, Raises Full Year Revenue Guidance

Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2017 financial results, including: Total revenues of $3.

Alisha A. Alaimo Appointed SVP Of Biogen's US Therapeutic Operations

Alisha A. Alaimo Appointed SVP Of Biogen's US Therapeutic Operations

Biogen (NASDAQ: BIIB) announced today the appointment of Alisha A.

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

Wall Street's first glimpse at the second quarter.

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

Here are the activist investor's next potential targets.

These Are the Best Growth Stocks Right Now in Biotech

These Are the Best Growth Stocks Right Now in Biotech

Top names.

Biogen To Present Data At Alzheimer's Association International Conference® 2017 (AAIC®)

Biogen To Present Data At Alzheimer's Association International Conference® 2017 (AAIC®)

Biogen (NASDAQ: BIIB) will present data from its Alzheimer's disease programs at the Alzheimer's Association International Conference® 2017 (AAIC®) in London, July 16 - 20, 2017.

3 Red-Hot Biotech Stocks That Could Get Even Hotter

3 Red-Hot Biotech Stocks That Could Get Even Hotter

An analyst weighs in.

Biogen Appoints Amy Chevalier Efantis Vice President Of Government Affairs

Biogen Appoints Amy Chevalier Efantis Vice President Of Government Affairs

Biogen (NASDAQ: BIIB) announced today the appointment of Amy Chevalier Efantis as Vice President of Government Affairs, effective July 17.

New Data Reaffirm Clinically Meaningful Benefit Of SPINRAZA® (nusinersen) In Individuals With Spinal Muscular Atrophy Across Disease Severity

New Data Reaffirm Clinically Meaningful Benefit Of SPINRAZA® (nusinersen) In Individuals With Spinal Muscular Atrophy Across Disease Severity

Biogen (NASDAQ: BIIB) will present robust efficacy and safety data from Phase 2 and 3 SPINRAZA ® (nusinersen) studies at the Cure SMA 2017 Annual SMA Conference in Orlando, Fl, June 29 - July 2, 2017.

Biogen Appoints Catherine Steele Senior Vice President Of Corporate Affairs

Biogen (NASDAQ: BIIB) announced today the appointment of Catherine Steele as Senior Vice President of Corporate Affairs, effective July 17.

Biogen's IMRALDI®, An Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive Opinion By Committee For Medicinal Products For Human Use

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for IMRALDI ® (also known as SB5), an adalimumab biosimilar candidate referencing...

Healthcare Stock Rally Can't Save S&P 500 From Another Bad Day

Healthcare Stock Rally Can't Save S&P 500 From Another Bad Day

Healthcare leads markets after the release of the Senate health plan.

Nasdaq Leads Wall Street, Healthcare Stocks Rise on Senate Bill

Nasdaq Leads Wall Street, Healthcare Stocks Rise on Senate Bill

Healthcare leads markets after the release of the Senate health plan.